IDH2 and acute myeloid leukemia: Mutations in IDH2 have been first reported in glioblastoma multiforme, next in acute myeloid leukemia, and other malignancies such as breast invasive ductal carcinoma, colon adenocarcinoma, lung adenocarcinoma, and oligodendroglioma.